BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 120 filers reported holding BIODELIVERY SCIENCES INTL IN in Q3 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $584,000 | -15.4% | 188,773 | -1.2% | 0.02% | -18.2% |
| Q3 2021 | $690,000 | +0.1% | 191,100 | -0.7% | 0.02% | -4.3% |
| Q2 2021 | $689,000 | -8.4% | 192,400 | 0.0% | 0.02% | -14.8% |
| Q1 2021 | $752,000 | -1.4% | 192,400 | +5.9% | 0.03% | +3.8% |
| Q4 2020 | $763,000 | +11.1% | 181,600 | -1.4% | 0.03% | +18.2% |
| Q3 2020 | $687,000 | -38.7% | 184,200 | -28.4% | 0.02% | -29.0% |
| Q2 2020 | $1,120,000 | -10.5% | 257,087 | -22.2% | 0.03% | -16.2% |
| Q1 2020 | $1,252,000 | -51.2% | 330,399 | -18.6% | 0.04% | -37.3% |
| Q4 2019 | $2,567,000 | +32.9% | 406,099 | -11.5% | 0.06% | +37.2% |
| Q3 2019 | $1,932,000 | +27.9% | 458,999 | +41.3% | 0.04% | +26.5% |
| Q2 2019 | $1,510,000 | -41.3% | 324,888 | -33.0% | 0.03% | -34.6% |
| Q1 2019 | $2,571,000 | – | 485,100 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,575,000 | $6,615,000 | 4.38% |
| 1492 Capital Management LLC | 790,863 | $3,322,000 | 1.91% |
| Rubric Capital Management LP | 3,516,124 | $14,768,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,530,000 | $40,026,000 | 0.79% |
| Zebra Capital Management LLC | 144,241 | $606,000 | 0.77% |
| KNOTT DAVID M | 370,230 | $1,555,000 | 0.70% |
| Nantahala Capital Management | 5,123,671 | $21,519,000 | 0.67% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 3,593,893 | $15,094,000 | 0.66% |
| EMC Capital Management | 98,933 | $416,000 | 0.32% |
| ALGERT GLOBAL LLC | 175,170 | $736,000 | 0.21% |